Insight

At a crossroads, Ironwood CEO Peter Hecht maps a big leap forward

At a crossroads, Ironwood CEO Peter Hecht maps a big leap forward

"We want to build a standalone, great pharmaceutical company. The ambition isn't size, it’s quality and making drugs that really matter.” — Peter Hecht, 2009.

Johnson & Johnson Innovation pushes for digital health partnerships

Johnson & Johnson Innovation pushes for digital health partnerships


Aug 27, 2016

Johnson & Johnson sees digital health technology as one part of a larger mix of solutions as the industry moves toward precision medicine and a...

Boehringer Ingelheim’s new R&D strategy focuses on external innovation

Boehringer Ingelheim’s new R&D strategy focuses on external innovation


Aug 27, 2016

"We are truly interested in innovative science no matter where it originates. Paving the way for business collaborations at Boehringer Ingelheim starts with a mindset—shared...

partnering360®: leverage and cultivate your dealmaker network

partnering360 is the network for dealmakers in the life science industry. This global community of more than 36,000 is constantly growing, and the partnering opportunities continually updating.